Literature DB >> 27338856

Minimal vascular flows cause strong heat sink effects in hepatic radiofrequency ablation ex vivo.

Kai S Lehmann1, Franz G M Poch1, Christian Rieder2, Andrea Schenk2, Andrea Stroux3, Bernd B Frericks4, Ole Gemeinhardt1, Christoph Holmer1, Martin E Kreis1, Jörg P Ritz5, Urte Zurbuchen1.   

Abstract

BACKGROUND: The present paper aims to assess the lower threshold of vascular flow rate on the heat sink effect in bipolar radiofrequency ablation (RFA) ex vivo.
METHODS: Glass tubes (vessels) of 3.4 mm inner diameter were introduced in parallel to bipolar RFA applicators into porcine liver ex vivo. Vessels were perfused with flow rates of 0 to 1,500 ml/min. RFA (30 W power, 15 kJ energy input) was carried out at room temperature and 37°C. Heat sink effects were assessed in RFA cross sections by the decrease in ablation radius, area and by a high-resolution sector planimetry.
RESULTS: Flow rates of 1 ml/min already caused a significant cooling effect (P ≤ 0.001). The heat sink effect reached a maximum at 10 ml/min (18.4 mm/s) and remained stable for flow rates up to 1,500 ml/min.
CONCLUSIONS: Minimal vascular flows of ≥1 ml/min cause a significant heat sink effect in hepatic RFA ex vivo. A lower limit for volumetric flow rate was not found. The maximum of the heat sink effect was reached at a flow rate of 10 ml/min and remained stable for flow rates up to 1,500 ml/min. Hepatic inflow occlusion should be considered in RFA close to hepatic vessels.
© 2016 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Bipolar; Cooling effect; Heat sink; Liver metastases; Radiofrequency ablation

Mesh:

Year:  2016        PMID: 27338856     DOI: 10.1002/jhbp.370

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  7 in total

1.  Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial).

Authors:  Michael Moche; Harald Busse; Jurgen J Futterer; Camila A Hinestrosa; Daniel Seider; Philipp Brandmaier; Marina Kolesnik; Sjoerd Jenniskens; Roberto Blanco Sequeiros; Gaber Komar; Mika Pollari; Martin Eibisberger; Horst Rupert Portugaller; Philip Voglreiter; Ronan Flanagan; Panchatcharam Mariappan; Martin Reinhardt
Journal:  Eur Radiol       Date:  2019-08-30       Impact factor: 5.315

Review 2.  Usefulness of ultrasound fusion technology for hepatocellular carcinoma localisation, pre- and post-thermal ablation.

Authors:  A Mohamed Afif; O D Laroco; Smd Lau; S M Teo; As Abdul Rahman; C W Too; N Venkatanarasimha; A Gogna
Journal:  Ultrasound       Date:  2021-10-03

3.  Intermittent Pringle maneuver may be beneficial for radiofrequency ablations in situations with tumor-vessel proximity.

Authors:  Franz G M Poch; Christina A Neizert; Ole Gemeinhardt; Beatrice Geyer; Katharina Eminger; Christian Rieder; Stefan M Niehues; Janis Vahldiek; Stefan F Thieme; Kai S Lehmann
Journal:  Innov Surg Sci       Date:  2018-05-11

Review 4.  Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go.

Authors:  Kunpeng Wang; Cong Wang; Hao Jiang; Yaqiong Zhang; Weidong Lin; Jinggang Mo; Chong Jin
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

5.  Three-dimensional assessment of vascular cooling effects on hepatic microwave ablation in a standardized ex vivo model.

Authors:  C A Neizert; H N C Do; M Zibell; C Rieder; D Sinden; S M Niehues; J L Vahldiek; K S Lehmann; F G M Poch
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

6.  Perivascular vital cells in the ablation center after multibipolar radiofrequency ablation in an in vivo porcine model.

Authors:  F G M Poch; C A Neizert; B Geyer; O Gemeinhardt; S M Niehues; J L Vahldiek; K K Bressem; K S Lehmann
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

7.  Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Jie Han; Yu-Chen Fan; Kai Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.